Peptic Ulcer Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Peptic Ulcer Drugs Market
The peptic ulcer drugs market size was valued at USD 4.25 billion in 2019, and the market is now projected to grow from USD 4.25 billion in 2019 to USD 5.13 billion by 2027, exhibiting a CAGR of 2.4% during the forecast period of 2019-2027.
Pharmaceutical like AstraZeneca is experiencing boom regardless of the pandemic. They have stepped forward delivery chain, R&D abilities and production control. Government regulations have relaxed, allowing physicians to offer telemedicine care. As a result, sales growth is anticipated to hold regardless of the COVID-19.
Approved steroidal anti-inflammatory drugs offer faster and less expensive healthcare access, increasing their popularity. Pharmaceutical companies are investing in growing OTC variations of peptic ulcer drugs, that is expected to power peptic ulcer drugs market growth within the future.
Peptic ulcers affect 10% of the arena's populace, with four million people struggling yearly within the U.S. The main purpose is H. Pylori bacterium infection and elevated NSAID consumption. The disease is on the whole affecting older individuals, with high occurrence between 55 and 65 years old. The developing geriatric populace is contributing to the worldwide marketplace enlargement, highlighting the need for effective treatments and prevention techniques.
Comprehensive Analysis of Peptic Ulcer Drugs Market
The marketplace is divided into antibiotics, proton pump inhibitors, and gastric ulcers. Antibiotics held the dominant market share due to excessive adoption rate and triple therapy treatment for Helicobacter pylori infection. Proton pump inhibitors are anticipated to develop drastically with the very best CAGR. The marketplace is segmented into gastric and duodenal ulcers, with duodenal ulcers main because of the growing incidence and consciousness of treatment options. Distribution channels consist of clinic pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to have the largest marketplace proportion due to improved affected person visits and the ease of availability. The growing recognition of online pharmacies is anticipated to in addition increase the segment's growth.
The North America region lead the peptic ulcer drugs market share by benefitting a market size of USD 1.76 billion in 2019 due to developing prevalence of peptic ulcers, with approximately 4 million human beings struggling every year.
Key organizations includes AstraZeneca, Novartis AG GlaxoSmithKline %, Takeda Pharmaceutical Company Limited, Mylan Pharmaceuticals Inc., Abbott and Zydus Cadila.
Famotidine to cope with belly ulcers is below research at Northwell Health in New York City as a remedy for the covid-19.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD billion)
SegmentationDrug Type; Ulcer Type; End User and Geography
By Drug Type
Proton Pump Inhibitors
H2 Antagonists
Antibiotics
Others
By Ulcer Type
Gastric Ulcer
Duodenal Ulcer
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography
North America (USA, Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia, Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia,Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, South Africa,Rest of MEA)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Peptic Ulcer, By Country/Region
- 4.2. Pipeline Analysis, By Key Players
- 4.3. Recent Industry Developments
- 4.4. Regulatory Scenario-by Key Countries
- 4.5. Impact of COVID-19 on Peptic Ulcer Drugs Market
- 5. Global Peptic Ulcer Drugs Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Drug Type
- 5.2.1. Proton Pump Inhibitor
- 5.2.2. H2 Antagonists
- 5.2.3. Antibiotics
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By Ulcer Type
- 5.3.1. Gastric Ulcer
- 5.3.2. Duodenal Ulcer
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospital Pharmacies
- 5.4.2. Retail Pharmacies
- 5.4.3. Online Pharmacies
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Peptic Ulcer Drugs Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Drug Type
- 6.2.1. Proton Pump Inhibitor
- 6.2.2. H2 Antagonists
- 6.2.3. Antibiotics
- 6.2.4. Others
- 6.3. Market Analysis – By Ulcer Type
- 6.3.1. Gastric Ulcer
- 6.3.2. Duodenal Ulcer
- 6.4. Market Analysis – By End User
- 6.4.1. Hospital Pharmacies
- 6.4.2. Retail Pharmacies
- 6.4.3. Online Pharmacies
- 6.5. Market Analysis – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Peptic Ulcer Drugs Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Drug Type
- 7.2.1. Proton Pump Inhibitor
- 7.2.2. H2 Antagonists
- 7.2.3. Antibiotics
- 7.2.4. Others
- 7.3. Market Analysis – By Ulcer Type
- 7.3.1. Gastric Ulcer
- 7.3.2. Duodenal Ulcer
- 7.4. Market Analysis – By End User
- 7.4.1. Hospital Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Online Pharmacies
- 7.5. Market Analysis – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Peptic Ulcer Drugs Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Drug Type
- 8.2.1. Proton Pump Inhibitor
- 8.2.2. H2 Antagonists
- 8.2.3. Antibiotics
- 8.2.4. Others
- 8.3. Market Analysis – By Ulcer Type
- 8.3.1. Gastric Ulcer
- 8.3.2. Duodenal Ulcer
- 8.4. Market Analysis – By End User
- 8.4.1. Hospital Pharmacies
- 8.4.2. Retail Pharmacies
- 8.4.3. Online Pharmacies
- 8.5. Market Analysis – By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Peptic Ulcer Drugs Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Drug Type
- 9.2.1. Proton Pump Inhibitor
- 9.2.2. H2 Antagonists
- 9.2.3. Antibiotics
- 9.2.4. Others
- 9.3. Market Analysis – By Ulcer Type
- 9.3.1. Gastric Ulcer
- 9.3.2. Duodenal Ulcer
- 9.4. Market Analysis – By End User
- 9.4.1. Hospital Pharmacies
- 9.4.2. Retail Pharmacies
- 9.4.3. Online Pharmacies
- 9.5. Market Analysis – By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Peptic Ulcer Drugs Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Drug Type
- 10.2.1. Proton Pump Inhibitor
- 10.2.2. H2 Antagonists
- 10.2.3. Antibiotics
- 10.2.4. Others
- 10.3. Market Analysis – By Ulcer Type
- 10.3.1. Gastric Ulcer
- 10.3.2. Duodenal Ulcer
- 10.4. Market Analysis – By End User
- 10.4.1. Hospital Pharmacies
- 10.4.2. Retail Pharmacies
- 10.4.3. Online Pharmacies
- 10.5. Market Analysis – By Country/Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2019)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
- 11.5.1. AstraZeneca
- 11.5.1.1. Overview,
- 11.5.1.2. Products & Services,
- 11.5.1.3. SWOT Analysis,
- 11.5.1.4. Recent Developments,
- 11.5.1.5. Strategies,
- 11.5.1.6. Financials (based on availability)
- 11.5.2. Novartis AG
- 11.5.2.1. Overview,
- 11.5.2.2. Products & Services,
- 11.5.2.3. SWOT Analysis,
- 11.5.2.4. Recent Developments,
- 11.5.2.5. Strategies,
- 11.5.2.6. Financials (based on availability)
- 11.5.3. Pfizer Inc.
- 11.5.3.1. Overview,
- 11.5.3.2. Products & Services,
- 11.5.3.3. SWOT Analysis,
- 11.5.3.4. Recent Developments,
- 11.5.3.5. Strategies,
- 11.5.3.6. Financials (based on availability)
- 11.5.4. GlaxoSmithKline plc.
- 11.5.4.1. Overview,
- 11.5.4.2. Products & Services,
- 11.5.4.3. SWOT Analysis,
- 11.5.4.4. Recent Developments,
- 11.5.4.5. Strategies,
- 11.5.4.6. Financials (based on availability)
- 11.5.5. Takeda Pharmaceutical Company Limited.
- 11.5.5.1. Overview,
- 11.5.5.2. Products & Services,
- 11.5.5.3. SWOT Analysis,
- 11.5.5.4. Recent Developments,
- 11.5.5.5. Strategies,
- 11.5.5.6. Financials (based on availability)
- 11.5.6. Mylan Pharmaceuticals Inc.
- 11.5.6.1. Overview,
- 11.5.6.2. Products & Services,
- 11.5.6.3. SWOT Analysis,
- 11.5.6.4. Recent Developments,
- 11.5.6.5. Strategies,
- 11.5.6.6. Financials (based on availability)
- 11.5.7. Abbott
- 11.5.7.1. Overview,
- 11.5.7.2. Products & Services,
- 11.5.7.3. SWOT Analysis,
- 11.5.7.4. Recent Developments,
- 11.5.7.5. Strategies,
- 11.5.7.6. Financials (based on availability)
- 11.5.8. Zydus Cadila
- 11.5.8.1. Overview,
- 11.5.8.2. Products & Services,
- 11.5.8.3. SWOT Analysis,
- 11.5.8.4. Recent Developments,
- 11.5.8.5. Strategies,
- 11.5.8.6. Financials (based on availability)
- 11.5.9. Other Players
- 11.5.9.1. Overview,
- 11.5.9.2. Products & Services,
- 11.5.9.3. SWOT Analysis,
- 11.5.9.4. Recent Developments,
- 11.5.9.5. Strategies,
- 11.5.9.6. Financials (based on availability)
- 12. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook